You have 9 free searches left this month | for more free features.

Gallium-68

Showing 1 - 25 of 655

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (68Ga-DOTATOC)

Not yet recruiting
  • Advanced Gastroenteropancreatic Neuroendocrine Tumor
  • (no location specified)
Oct 16, 2023

Myocardial Fibrosis Trial in Nanjing (68Ga/18F-FAPI-04)

Recruiting
  • Myocardial Fibrosis
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
May 11, 2023

Neuroendocrine Tumors Trial in Beijing, Fuzhou (Gallium-68 NODAGA-JR11)

Recruiting
  • Neuroendocrine Tumors
  • Gallium-68 NODAGA-JR11
  • Beijing, Beijing, China
  • +1 more
Jul 27, 2022

Hepatocellular Carcinoma Trial in Rochester (Gallium Ga 68 Gozetotide, Hepatic Artery Embolization, Positron Emission Tomography

Recruiting
  • Hepatocellular Carcinoma
  • Gallium Ga 68 Gozetotide
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 11, 2023

Endometrial Cancer Trial (Gallium-68-tilmanocept)

Not yet recruiting
  • Endometrial Cancer
  • (no location specified)
Jun 30, 2022

Ganglioneuroblastoma, Ganglioneuroma, Metastatic Neuroblastoma Trial in Rochester (Computed Tomography, Gallium Ga 68-DOTATATE,

Recruiting
  • Ganglioneuroblastoma
  • +2 more
  • Computed Tomography
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 30, 2023

Prostate Cancer, Prostate Adenocarcinoma, Prostate Cancer Metastatic Trial in Ann Arbor (68Ga-PSMA)

Active, not recruiting
  • Prostate Cancer
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan
Mar 10, 2022

Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Houston (Computed

Not yet recruiting
  • Metastatic Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 10, 2022

68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy

Enrolling by invitation
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Computed Tomography
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 16, 2023

Infective Endocarditis Trial in Bordeaux (68Ga-citrate PET/CT)

Not yet recruiting
  • Infective Endocarditis
  • 68Ga-citrate PET/CT
  • Bordeaux, France
    CHU de Bordeaux
Jul 6, 2022

Meningioma Trial in Houston (Computed Tomography, Gallium Ga 68-DOTATATE, Positron Emission Tomography)

Recruiting
  • Meningioma
  • Computed Tomography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 28, 2022

Neuroendocrine Tumors Trial in Beijing (Gallium-68 NODAGA-LM3 PET/CT, Gallium-68 DOTA-LM3 PET/CT, Gallium-68 DOTATATE PET/CT)

Completed
  • Neuroendocrine Tumors
  • Gallium-68 NODAGA-LM3 PET/CT
  • +2 more
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Dec 20, 2021

Prostate Adenocarcinoma Trial (68Ga-PSMA-11)

Available
  • Prostate Adenocarcinoma
  • (no location specified)
Jun 10, 2022

Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Los Angeles (drug,

Not yet recruiting
  • Prostate Adenocarcinoma
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 5, 2023

Bladder Cancer Trial in Shanghai ([68Ga]-NOTA-SGC8)

Recruiting
  • Bladder Cancer
  • [68Ga]-NOTA-SGC8
  • Shanghai, Shanghai, China
    Renji Hospital
Aug 14, 2023

Biochemically Recurrent Prostate Carcinoma Trial in Duarte (Gallium Ga 68-labeled PSMA-11, Positron Emission Tomography)

Suspended
  • Biochemically Recurrent Prostate Carcinoma
  • Gallium Ga 68-labeled PSMA-11
  • Positron Emission Tomography
  • Duarte, California
    City of Hope Medical Center
Oct 12, 2022

Breast Cancer Stage IV Trial in Irvine (Gallium-68)

Recruiting
  • Breast Cancer Stage IV
  • Gallium-68
  • Irvine, California
    Hoag Memorial Hospital Presbyterian
May 26, 2023

Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Los Angeles (Computed Tomography, Gallium Ga 68 FAPi-46,

Recruiting
  • Breast Carcinoma
  • +10 more
  • Computed Tomography
  • +4 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Nov 29, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Biopsy
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Nov 17, 2023

Biochemically Recurrent Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Los

Terminated
  • Biochemically Recurrent Prostate Carcinoma
  • +5 more
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    University of California at Los Angeles / Jonsson Comprehensive
Oct 19, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on

Terminated
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 19, 2022

Metastic Thyroid Cancer Trial run by the NIDDK (68-Gallium-DOTATATE-PET/CT)

Recruiting
  • Metastic Thyroid Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 28, 2023

Solid Tumors, Adult, Metastatic Cancer Trial in San Francisco (Gallium-68 labelled (68Ga-) FAP-2286, Positron Emission

Recruiting
  • Solid Tumors, Adult
  • Metastatic Cancer
  • Gallium-68 labelled (68Ga-) FAP-2286
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Aug 1, 2022

Malignant Tumor Trial in Wuhan (68Ga-HX01)

Recruiting
  • Malignant Neoplasm
  • Wuhan, Hubei, China
    China, Hubei Province
Aug 5, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in Atlanta (CT

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • CT (Computed Tomography)
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Mar 3, 2022